I would say MSA is crucial if they want to sell in the US. Can you imagine the bottom feeders that would try to come out with lawsuits after they recieve the news they got lung cancer. "But it's supposed to be reduced risk...I'm suing!!"
Technically, sell stops that are under 2.15 does not bode well if taken out and its too close for comfort. Bearish insider sells and shelf reg still weigh heavily on sentiment near term. Without revenue news, I expect continued pressure playing on long term support in the 1.70 - 1.80 zone.............GTTA
Market Data 
Markets 
AI
